GeneFrontier Corporation (GFC) is a Japanese biotech company, which is one of the group companies of KANEKA Corporation. GFC is focusing on biopharmaceutical R&D support business with innovative products and services especially in protein based biologics including antibody.
GFC entered into the partnership with MorphoSys AG since 2004, and has been collaborating together for great success so far. Along with that partnership, GFC has been exclusively distributing HuCAL monoclonal development services in Japan as a Japanese professional of HuCAL which is a cutting edge antibody technology of MorphoSys AG.
Also, GFC is looking at next era of antibody therapeutics in Biologics. GFC is developing its own new technology for antibody therapeutics and beyond antibodies, like scaffold.
Our aim is to explore the potential of protein based Biologics, and contributes the development of innovative therapeutics.